Resistant dermatomyositis as a manifestation of post COVID-19 infection: A case report
DOI:
https://doi.org/10.54029/2023jsyKeywords:
dermatomyositis, covid-19, autoimmuneAbstract
Many autoimmune diseases were reported as a sequel of SARS CoV-2 infection. We report here a 51-year-old female who presented with myalgia, progressive quadriparesis, and skin rash 2 weeks after COVID-19 infection. She improved with high-dose methylprednisolone. She was given oral methotrexate and mycophenolic acid during follow up. However, her condition deteriorated until she passed away half a year after the initial illness. This case showed that dermatomyositis can be associated with COVID-19 infection.
Published
2023-07-01
Issue
Section
Case Report